nivolumab,brentuximab,doxorubicin hydrochloride,dacarbazine,filgrastim,pegfilgrastim,vinblastine sulfate
seagen,bms,amgen
[]
dr. ann lacasce ( ) presents on lba4 as plenary discussant at #asco23. 
Dana-Farber Cancer Institute - a leading center for expert, compassionate cancer care and advanced research.
Appts: 877-442-3324 | https://t.co/HvCwkLltic